Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia
Clinical trial NCT01700413 · COMPLETED
Trial details
- NCT number
- NCT01700413
- Sponsor
- Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.